Company: JUNS
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010990
Chunk: 2

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Item 1
Chunk 2
---
ROSCIENCES, INC.

 CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

FOR THE MONTHS ENDED MARCH 31, 2025 AND 2024

(Unaudited)

    Common Stock  
    Additional Paid  
    Accumulated  
    Total Stockholders’ Equity  

    Shares  
    Amount  
    in Capital  
    Deficit  
    (Deficit) 
  
    December 31, 2024 
     33,103,860  
    $3,310  
    $30,190,827  
    $(26,022,129) 
    $4,172,008 
  
    Stock-based compensation 
     -  
     -  
     421,454  
     -  
     421,454 
  
    Net loss 
     -  
     -  
     -  
     (1,528,867) 
     (1,528,867)
  
    March 31, 2025 
     33,103,860  
    $3,310  
    $30,612,281  
    $(27,550,996) 
    $3,064,595 

    Common Stock  
    Additional Paid  
    Accumulated  
    Total Stockholders’ Equity  

    Shares  
    Amount  
    in Capital  
    Deficit  
    (Deficit) 
  
    December 31, 2023 
     26,526,405  
    $3,310  
    $17,778,498  
    $(23,582,504) 
    $(5,801,354)
  
    Balance 
     26,526,405  
    $3,310  
    $17,778,498  
    $(23,582,504) 
    $(5,801,354)

    Stock-based compensation 
     -  
     -  
     355,317  
     -  
     355,317 
  
    Issuance of restricted stock for the forgiveness of accrued salaries and accrued bonuses 
     -  
     -  
     10,000  
     -  
     10,000 
  
    Issuance of stock